药品研发生产
Search documents
海南封关,江苏开放再迎新机遇
Xin Hua Ri Bao· 2025-12-18 23:47
□ 本报记者 王梦然 12月18日,海南自由贸易港全岛封关运作正式启动。当天上午,南京江北新区生物医药谷会议室内,江 苏鼎泰药物研究(集团)股份有限公司工作人员正通过视频系统与海南文昌基地的团队连线。屏幕上实时 显示着实验猴舍内的画面,食蟹猴灵活地攀爬、跳跃,表现出高度的活力。"我们早在3年前就布局海 南,封关后,我们的实验动物进出口将享受更多便利。"工作人员指着屏幕说,今后全球研发合作通道 将更加顺畅。 业内认为,海南封关为江苏制造提供了一个"境内关外"的战略跳板,江苏企业可以依托海南,实现"全 球采购、国际加工、离岸销售"的新型商业模式,这不仅仅是成本节约,更是全球资源配置能力的跃 升。从制造业的"借船出海",到生物医药的"研发+转化",再到数字经济的"规则共建"……江苏将凭借 雄厚的产业基础和创新实力,成为这场改革中活跃的参与者与受益者。 巧借政策跳板,便利制造出海 鼎泰药研(集团)是这一模式的先行者。早在2022年,这家总部位于南京江北新区的CRO企业就开始 在海南文昌布局。"我们用时一年,建成了海南亚灵生物科技有限公司,并持续引进高质种群,公司拥 有国内规模最大的非人灵长类动物(NHP)研究核心年轻 ...
华人健康(301408) - 2025年5月8日投资者关系活动记录表
2025-05-08 10:34
Financial Performance - In 2024, the company's revenue reached CNY 4.532 billion, representing a growth of 19.34% compared to the previous year [2] - The net profit attributable to the parent company was CNY 138 million, marking a 20.09% increase year-on-year [2] R&D Investment Plans - Future R&D will focus on two main areas: 1. Digital empowerment and technology application, enhancing management efficiency and operational capabilities [3] 2. Drug research and capacity expansion, accelerating product development and leveraging advantages in fermentation technology [3] Store Expansion Strategy - In 2024, the company added 440 new stores through acquisitions, with plans to continue expanding its retail presence in the Anhui region and surrounding areas [3] Competitive Strategies - The company aims to strengthen its market position through: 1. Brand building and promotion to enhance market visibility [4] 2. Engaging in social responsibility initiatives to improve public perception [4] 3. Deepening member services to increase customer loyalty [4] 4. Implementing refined management practices to boost operational efficiency [5] 2025 Development Goals - The company plans to maintain a balanced development across its four core business segments: retail, agency, terminal procurement, and R&D [5] - It aims to enhance its brand market share and continue digital transformation efforts to support business growth [5] Response to Industry Policy Changes - The company is adapting to policy changes by: 1. Increasing R&D investment in high-potential products to enhance competitiveness [7] 2. Improving operational efficiency and cost management through digital transformation [7] 3. Strengthening brand and service value to maintain customer loyalty [7] 4. Actively participating in policy discussions to leverage market opportunities [7]